-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCRYST PHARMACEUTICALS, - CASH, CASH EQUIVALENTS, RESTRICTED CASH AND INVESTMENTS $354 MLN AT JUNE 30, 2026

Reuters·08/05/2026 11:00:02

Please log in to view news